Condition
Inflammatory Bowel Disease - IBD1
ClinicalTrials.gov condition label
Clinical trials
1 shownCommon interventions
ZL-82 100mgDRUG1ZL-82 12.5mgDRUG1ZL-82 200mgDRUG1ZL-82 25mgDRUG1ZL-82 300mgDRUG1ZL-82 450mgDRUG1ZL-82 50mgDRUG1ZL-82 600mgDRUG1ZL-82 placebo 100mgDRUG1zL-82 placebo 12.5mgDRUG1ZL-82 placebo 200mgDRUG1ZL-82 placebo 25mgDRUG1ZL-82 placebo 300mgDRUG1ZL-82 placebo 450mgDRUG1ZL-82 placebo 50mgDRUG1ZL-82 placebo 600mgDRUG1
Leading sponsors
Trial status mix
COMPLETED1
Phase mix
PHASE11
How to interpret this record
CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.